SAGE-217 in Major Depressive Disorder: A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial

Mittal, A; Clayton, A; Lasser, R; Nandy, I; Sankoh, A; Campbell, A; Werneburg, B; Silber, C; Jonas, J; Kanes, S; Gunduz-Bruce, H

NEUROLOGY, 2020; 94 (15):